# Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)

> **NCT04400019** · PHASE2,PHASE3 · UNKNOWN · sponsor: **University of Malaga** · enrollment: 1930 (estimated)

## Conditions studied

- Sars-CoV2
- Coronavirus Infection
- Prevention & Control
- Nursing Home
- Hydroxychloroquine

## Interventions

- **DRUG:** Hydroxychloroquine Only Product in Oral Dose Form

## Key facts

- **NCT ID:** NCT04400019
- **Lead sponsor:** University of Malaga
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-09
- **Primary completion:** 2020-12-15
- **Final completion:** 2021-04-01
- **Target enrollment:** 1930 (ESTIMATED)
- **Last updated:** 2020-09-29

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04400019

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04400019, "Prevention of COVID19 Infection in Nursing Homes by Chemoprophylaxis With Hydroxychloroquine (PREVICHARM)". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT04400019. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*